About the Authors
- Kirthana Sharma
-
Roles Conceptualization, Data curation, Formal analysis, Methodology, Writing – original draft, Writing – review & editing
* E-mail: ksharma@globalhealth.rutgers.edu
Affiliations Rutgers Global Health Institute, New Brunswick, New Jersey, United States of America, Department of Medicine, Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States of America
- Tina Mayer
-
Roles Conceptualization, Data curation, Methodology, Writing – original draft, Writing – review & editing
Affiliation Division of Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States of America
- Sharon Li
-
Roles Conceptualization, Data curation, Methodology, Writing – original draft, Writing – review & editing
Affiliation Rutgers Cancer Institute at University Hospital, New Jersey Medical School, Newark, New Jersey, United States of America
- Sadaf Qureshi
-
Roles Conceptualization, Data curation, Methodology, Writing – original draft, Writing – review & editing
Affiliation Division of Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States of America
- Faheem Farooq
-
Roles Conceptualization, Data curation, Methodology, Writing – original draft, Writing – review & editing
Affiliation Division of Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States of America
- Peter Vuylsteke
-
Roles Writing – review & editing
Affiliation Department of Internal Medicine, University of Botswana, Gaborone, Botswana
- Tlotlo Ralefala
-
Roles Writing – review & editing
Affiliation Department of Oncology, Princess Marina Hospital, Gaborone, Botswana
- Richard Marlink
-
Roles Conceptualization, Methodology, Writing – review & editing
Affiliations Rutgers Global Health Institute, New Brunswick, New Jersey, United States of America, Department of Medicine, Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States of America
Competing Interests
KS and RM receive funding from Bristol Myers Squibb. TM is receiving or has received funding from EMD Sereno, Exelixis, Blue Earth Diagnostics, Aptitude Health, Novartis, AstraZeneca, Impact Network, Sotio, Merck, Pfizer, Curium Pharma. PV is receiving or has received funding from Novartis, AstraZeneca, Lilly, Pfizer and Roche. There are no patents, products in development or marketed products associated with this research to declare. This does not alter our adherence to PLOS ONE policies on sharing data and materials.